HealthQuill Health
Researchers at the University of Cambridge have developed a wearable ‘smart choker’ to help people communicate after speech impairments resulting from surgery or conditions such as Parkinson’s, stroke or cerebral palsy.
Health Medical Pharma

‘Smart choker’ to help speech-impaired people talk with AI aid

Researchers at the University of Cambridge have developed a wearable ‘smart choker’ to help people communicate after speech impairments resulting from surgery or.

Read More
The West Asian Hashemite Kingdom of Jordan has been designated as the first country in the world to be verified by the WHO as having eliminated leprosy.
Drugs Health Pharma

Jordan becomes first WHO-verified nation in the world to eliminate leprosy

The West Asian Hashemite Kingdom of Jordan has been designated as the first country in the world to be verified by the WHO.

Read More
Denmark’s Novo Nordisk got the backing of the European Medicines Agency for its Wegovy drug to reduce heart failure in obese people.
Drugs Health Pharma

Novo’s Wegovy gets EMA nod to treat heart failure in obese people

Denmark’s Novo Nordisk got the backing of the European Medicines Agency for its Wegovy drug to reduce heart failure in obese people.

Read More
The imperative for the global governance of artificial intelligence (AI) is “irrefutable” as its accelerating development concentrates power and wealth on a global scale, according to a UN report.
Drugs Health Pharma

UN report calls for global governance of artificial intelligence

The imperative for the global governance of artificial intelligence (AI) is “irrefutable” as its accelerating development concentrates power and wealth on a global.

Read More
Vanda Pharmaceuticals Inc’s gastroparesis drug to treat a serious stomach condition was rejected by the Food and Drug Administration (FDA), which asked for additional studies, according to a company statement.
Drugs Health Pharma

FDA faces Vanda’s ire as it rejects firm’s gastroparesis drug application

Vanda Pharmaceuticals Inc’s gastroparesis drug to treat a serious stomach condition was rejected by the Food and Drug Administration (FDA), which asked for.

Read More
Researchers supported by the National Institutes of Health stopped a trial after they gathered sufficient evidence that an experimental drug to treat a rare bleeding disorder was safe and effective, according to a statement.
Drugs Health Pharma

Bleeding disorder trial halted after pomalidomide drug proves efficacy

Researchers supported by the National Institutes of Health stopped a trial after they gathered sufficient evidence that an experimental drug to treat a.

Read More
The US-based Biomedical Advanced Research and Development Authority will help Switzerland’s Basilea Pharmaceutica Ltd., to develop antifungals and antibacterials with an initial funding of $29 million.
Drugs Health Pharma

Basilea in $268m pact with BRDA for antifungals, antibacterials

The US-based Biomedical Advanced Research and Development Authority will help Switzerland’s Basilea Pharmaceutica Ltd., to develop antifungals and antibacterials with an initial funding.

Read More
Merck & Co’s combination drug, Keytruda, which treats advanced lung cancer, has been approved by the US drug regulator, the Food and Drug Administration.
Drugs Health Pharma

Merck’s advanced lung cancer drug gets US drug regulator’s nod

Merck & Co’s combination drug, Keytruda, which treats advanced lung cancer, has been approved by the US drug regulator, the Food and Drug.

Read More
Surgery-free cataracts may be possible in the future after researchers at the National Institutes of Health discovered a protein that can reverse and manage the clouding of the eye’s lens or lead to the development of a drug.
Drugs Health Pharma

Protein discovery in animal studies holds hope for surgery-free cataract

Surgery-free cataracts may be possible in the future after researchers at the National Institutes of Health discovered a protein that can reverse and.

Read More
US-based pharmaceutical company Organon & Co., will acquire Riovant Sciences Ltd’s arm — Dermavant Sciences Ltd., specialising in immuno-dermatology — for $1.2 billion.
Drugs Health Pharma

Organon & Co to buy Riovant’s arm Dermavant Sciences for $1.2 billion

US-based pharmaceutical company Organon & Co., will acquire Riovant Sciences Ltd’s arm — Dermavant Sciences Ltd., specialising in immuno-dermatology — for $1.2 billion.

Read More
X